These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 20971192)
1. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Yao M; Roberts DD; Isenberg JS Pharmacol Res; 2011 Jan; 63(1):13-22. PubMed ID: 20971192 [TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590 [TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells. Busch CJ; Graveline AR; Jiramongkolchai K; Liu H; Sanchez LS; Bloch KD J Physiol Pharmacol; 2010 Dec; 61(6):663-9. PubMed ID: 21224496 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway. Bouallegue A; Daou GB; Srivastava AK Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565 [TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation. Isenberg JS; Shiva S; Gladwin M Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167 [TBL] [Abstract][Full Text] [Related]
7. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222 [TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase. Dünnes S; Voussen B; Aue A; Groneberg K; Nikolaev V; Groneberg D; Friebe A Pflugers Arch; 2018 Apr; 470(4):693-702. PubMed ID: 29294149 [TBL] [Abstract][Full Text] [Related]
9. Endothelium-independent and endothelium-dependent vasorelaxation by a dichloromethane fraction from Anogeissus Leiocarpus (DC) Guill. Et Perr. (Combretaceae): possible involvement of cyclic nucleotide phosphodiesterase inhibition. Belemnaba L; Ouédraogo S; Auger C; Chataigneau T; Traore A; Guissou IP; Lugnier C; Schini-Kerth VB; Bucher B Afr J Tradit Complement Altern Med; 2013; 10(2):173-9. PubMed ID: 24146440 [TBL] [Abstract][Full Text] [Related]
10. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro. Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357 [TBL] [Abstract][Full Text] [Related]
11. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. Joshi CN; Martin DN; Fox JC; Mendelev NN; Brown TA; Tulis DA J Pharmacol Exp Ther; 2011 Nov; 339(2):394-402. PubMed ID: 21825001 [TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 1 regulation is a key mechanism in vascular aging. Bautista Niño PK; Durik M; Danser AH; de Vries R; Musterd-Bhaggoe UM; Meima ME; Kavousi M; Ghanbari M; Hoeijmakers JH; O'Donnell CJ; Franceschini N; Janssen GM; De Mey JG; Liu Y; Shanahan CM; Franco OH; Dehghan A; Roks AJ Clin Sci (Lond); 2015 Dec; 129(12):1061-75. PubMed ID: 26464516 [TBL] [Abstract][Full Text] [Related]
14. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948 [TBL] [Abstract][Full Text] [Related]
15. Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells. Kostic TS; Tomić M; Andric SA; Stojilkovic SS J Biol Chem; 2002 May; 277(19):16412-8. PubMed ID: 11867632 [TBL] [Abstract][Full Text] [Related]
16. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells. Wilson LS; Guo M; Umana MB; Maurice DH Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928 [TBL] [Abstract][Full Text] [Related]
17. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress. Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207 [TBL] [Abstract][Full Text] [Related]
18. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase. van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213 [TBL] [Abstract][Full Text] [Related]